Q2 2025 Holdings
Filed 2025-08-13 | 16 holdings | $82.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Plains GP Holdings LP-Cl(PAGPEUR) | COMM | 72651A207 | $24.7M | 1,272,360 | 30.0% |
| Achieve Life Sciences Inc(ACHV) | COMM | 004468500 | $13.9M | 6,153,091 | 16.9% |
| Akero Therapeutics Inc(AKRO) | COMM | 00973Y108 | $12.2M | 228,884 | 14.8% |
| Phathom Pharmaceuticals I(PHAT) | COMM | 71722W107 | $8.9M | 922,927 | 10.7% |
| Abeona Therapeutics Inc(ABEO) | COMM | 00289Y206 | $5.5M | 974,022 | 6.7% |
| Applied Therapeutics Inc(APLT) | COMM | 03828A101 | $3.5M | 11,285,420 | 4.3% |
| Milestone Pharmaceuticals(MIST) | COMM | 59935V107 | $3.5M | 1,791,557 | 4.2% |
| Delcath Systems Inc(DCTH) | COMM | 24661P807 | $3.1M | 226,052 | 3.7% |
| Tscan Therapeutics Inc(TCRX) | COMM | 89854M101 | $3.0M | 2,087,139 | 3.7% |
| Zevra Therapeutics Inc(ZVRA) | COMM | 488445206 | $2.0M | 231,874 | 2.5% |
| Capricor Therapeutics Inc(CAPR) | COMM | 14070B309 | $695.1K | 70,000 | 0.8% |
| Maat Pharma Saca | COMM | F5888J116 | $452.1K | 94,181 | 0.5% |
| Athira Pharma Inc | COMM | 04746L104 | $450.8K | 1,492,792 | 0.5% |
| Eiger Biopharmaceuticals(72C) | COMM | 28249U204 | $423.0K | 146,381 | 0.5% |
| WTS - Achieve Life Sci | COMM | 004468187 | $13.7K | 3,699,999 | 0.0% |
| Chinook Therapeutics(KDNY) | COMM | 169CVR016 | $2.5K | 79,357 | 0.0% |